Nevirapine XR (extended-release)

nevirapine · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nevirapine XR (extended-release), covering 2014-05-07 to 2014-05-07. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Multiple Dose Pharmacokinetic Study of Nevirapine Extended Release (XR) in HIV-1 Infected Children. [Phase 1]

See pricing